Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.620.600.530.420.49

What is the latest Fixed Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Fixed Capital/Sales ratio of BLISS GVS PHARMA is 0.62 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.62
Mar20240.60
Mar20230.53
Mar20220.42
Mar20210.49

How is Fixed Capital/Sales of BLISS GVS PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.62
3.33
Mar2024 0.6
13.21
Mar2023 0.53
26.19
Mar2022 0.42
-14.29
Mar2021 0.49 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Fixed Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,751.4 Cr 3.7% 9% 26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,160.0 Cr 1.7% 7.3% 0% Stock Analytics
DIVIS LABORATORIES ₹172,288.0 Cr 1.8% 0.9% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,440.0 Cr 1.3% 4.4% 14.9% Stock Analytics
CIPLA ₹123,149.0 Cr 0.9% -2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,369.0 Cr 0.5% -3.1% 3.3% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

3.7%

9%

26%

SENSEX

0.1%

1.1%

8.4%


You may also like the below Video Courses